why choose us

First received: October 20, 2023

Clinical Trial: Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Paroxysmal Nocturnal Hemoglobinuria

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Multicenter, Intra-Subject Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential of BCX10013 in Subjects with Paroxys

Brief Summary: This is a multicenter, open-label, intra-subject, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and therapeutic potential of BCX10013 in participants with PNH.Approximately 8 participants will be enrolled in this study.Participants may receive treatment for up to 52 weeks.

Read more